VASCULAR ACCESS SITE HAEMATOMA

This adverse event was reported 42 times

These drugs are most commonly taken by patients reporting VASCULAR ACCESS SITE HAEMATOMA:

# Drug Count
0 ASPIRIN 6
1 CLOPIDOGREL 6
2 CLOPIDOGREL BISULFATE 6
3 ASPIRIN 325 MG 5
4 ASPIRIN 81 MG 5
5 ALTEPLASE 4
6 VEDOLIZUMAB 4
7 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN 3
8 BIVALIRUDIN 2
9 HEPARIN SODIUM 2
See all common drugs associated with VASCULAR ACCESS SITE HAEMATOMA

VASCULAR ACCESS SITE HAEMATOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BIVALIRUDIN 2 0.0020
1 ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN 3 0.0008
2 TIROFIBAN 2 0.0007
3 ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE 1 0.0006
4 TENECTEPLASE 1 0.0006
5 ALTEPLASE 4 0.0003
6 HEPARIN SODIUM 2 0.0001
7 MINOCYCLINE 1 0.0001
8 EPLERENONE 1 0.0001
9 CLOPIDOGREL BISULFATE 6 0.0001
See all drugs enriched for association with VASCULAR ACCESS SITE HAEMATOMA